244 related articles for article (PubMed ID: 12831788)
1. Drug metabolites in safety testing.
Hastings KL; El-Hage J; Jacobs A; Leighton J; Morse D; Osterberg RE
Toxicol Appl Pharmacol; 2003 Jul; 190(1):91-2;author reply 93-4. PubMed ID: 12831788
[No Abstract] [Full Text] [Related]
2. Issues in the safety testing of metabolites.
Gross G; Wilson I
Future Med Chem; 2009 Nov; 1(8):1381-90. PubMed ID: 21426053
[No Abstract] [Full Text] [Related]
3. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.
Simmons HE
Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901
[No Abstract] [Full Text] [Related]
4. The early estimation of circulating drug metabolites in humans.
Luffer-Atlas D
Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):985-97. PubMed ID: 22681256
[TBL] [Abstract][Full Text] [Related]
5. Assessment of drug metabolites.
Izumi T
Drug Metab Pharmacokinet; 2011; 26(2):121-2. PubMed ID: 21532211
[No Abstract] [Full Text] [Related]
6. Pharmacokinetics and toxicokinetics of bio-pharmaceuticals: technical problems.
Kawai M
J Toxicol Sci; 1996 Dec; 21(5):535-7. PubMed ID: 9035067
[No Abstract] [Full Text] [Related]
7. Meeting the demands of regulatory requirements: the significance of ADME.
Guttendorf R
Bioanalysis; 2012 Jun; 4(12):1395-7. PubMed ID: 22793021
[No Abstract] [Full Text] [Related]
8. The EMEA guideline on first-in-human clinical trials and its impact on pharmaceutical development.
Milton MN; Horvath CJ
Toxicol Pathol; 2009 Apr; 37(3):363-71. PubMed ID: 19246571
[No Abstract] [Full Text] [Related]
9. To what extent can results of experimental studies be extrapolated in predicting adverse side effects of drugs in man?
Grimová J; Roubal Z; Dlabac A
Arch Toxicol Suppl; 1986; 9():240-3. PubMed ID: 3468902
[TBL] [Abstract][Full Text] [Related]
10. Application of pharmacokinetics in drug safety evaluation.
Singhvi SM; Keim GR; Migdalof BH
Regul Toxicol Pharmacol; 1985 Mar; 5(1):3-17. PubMed ID: 3991931
[TBL] [Abstract][Full Text] [Related]
11. Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism.
Baillie TA; Rettie AE
Drug Metab Pharmacokinet; 2011; 26(1):15-29. PubMed ID: 20978360
[TBL] [Abstract][Full Text] [Related]
12. Challenges and solutions to metabolites in safety testing: impact of the International Conference on Harmonization M3(R2) guidance.
Yu H; Bischoff D; Tweedie D
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1539-49. PubMed ID: 21067462
[TBL] [Abstract][Full Text] [Related]
13. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA.
WESTON JK; WESTON K
Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685
[No Abstract] [Full Text] [Related]
14. A decade of drug metabolite safety testing: industry and regulatory shared learning.
Luffer-Atlas D; Atrakchi A
Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):897-900. PubMed ID: 28797172
[No Abstract] [Full Text] [Related]
15. [FOOD - DRUG INTERACTIONS: TYPES AND MECHANISMS.].
Lemina EY; Churyukanov VV
Eksp Klin Farmakol; 2016; 79(11):41-44. PubMed ID: 29791108
[TBL] [Abstract][Full Text] [Related]
16. To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
Schwartz MI
Food Drug Law J; 2008; 63(1):1-33. PubMed ID: 18561453
[No Abstract] [Full Text] [Related]
17. Pragmatic approaches to determine the exposures of drug metabolites in preclinical and clinical subjects in the MIST evaluation of the clinical development phase.
Haglund J; Halldin MM; Brunnström A; Eklund G; Kautiainen A; Sandholm A; Iverson SL
Chem Res Toxicol; 2014 Apr; 27(4):601-10. PubMed ID: 24593263
[TBL] [Abstract][Full Text] [Related]
18. Drugs on the market.
JAMA; 1970 Feb; 211(7):1177. PubMed ID: 5466970
[No Abstract] [Full Text] [Related]
19. Organic chemistry in drug discovery.
MacCoss M; Baillie TA
Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
[TBL] [Abstract][Full Text] [Related]
20. Microdosing Studies in Children: A US Regulatory Perspective.
Roth-Cline M; Nelson RM
Clin Pharmacol Ther; 2015 Sep; 98(3):232-3. PubMed ID: 26095312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
